Melanoma defies ‘lockdown’: ongoing detection during Covid‐19 in central London
Autor: | E. L. Kulakov, A. A. Schauer, C. L. Martyn‐Simmons, Christopher B Bunker, E. V. J. Edmonds |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Skin Neoplasms Coronavirus disease 2019 (COVID-19) Referral Early detection Dermatology 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Suspected skin cancer Correspondence London Pandemic medicine Humans Surgical treatment Melanoma Referral and Consultation Neoplasm Staging business.industry Dermatology department COVID-19 medicine.disease 030220 oncology & carcinogenesis Critical Pathways business Delivery of Health Care |
Zdroj: | Clinical and Experimental Dermatology |
ISSN: | 1365-2230 0307-6938 |
DOI: | 10.1111/ced.14324 |
Popis: | The COVID‐19 pandemic has presented significant challenges for Dermatology services, particularly the diagnosis and management of malignant melanoma (MM). Early detection and definitive surgical treatment are key to improving MM prognosis, and in England there is a suspected skin cancer referral pathway that facilitates specialist Dermatology assessment within two weeks. Here, we describe the impact of COVID‐19 on MM detection, based on data from the a Dermatology Department in central London. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |